Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Over-the-Counter

Dr. Reddy's Laboratories, Inc.: Omeprazole Capsules Recalled Due to Metal Staple Contamination

Agency Publication Date: October 20, 2021
Share:
Sign in to monitor this recall

Summary

Dr. Reddy's Laboratories, Inc. is recalling approximately 8,976 bottles of Omeprazole Delayed-Release Capsules (20 mg) because a metal staple was found inside a bottle. These over-the-counter 24-hour acid reducer capsules were distributed by Cardinal Health in 14-count bottles within individual cartons. This recall was initiated following a customer complaint about the foreign object being mixed in with the medication capsules.

Risk

The presence of a metal staple in the medication bottle poses a serious risk of choking, dental injury, or internal damage if accidentally swallowed with a capsule. While only one complaint has been reported, the physical hazard could cause significant injury to the mouth, throat, or digestive tract.

What You Should Do

  1. Check your medicine cabinet for 14-count bottles of Omeprazole Delayed-Release Capsules, 20 mg (24 Hour) with NDC 70000-0232-1.
  2. Identify if your product is part of the recall by looking for code BT001594C on the bottle or carton.
  3. Stop using the medication immediately if it matches the affected code and do not swallow any capsules from the bottle.
  4. Contact your healthcare provider or pharmacist for guidance regarding your treatment and for instructions on how to return the product for a refund.
  5. Return any unused product to the pharmacy or place of purchase for a refund and contact Dr. Reddy's Laboratories, Inc. at 1-888-723-3332 for further instructions.
  6. Contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for additional information.

Your Remedy Options

💰Full Refund

Healthcare provider consultation and pharmacy refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Omeprazole Delayed-Release Capsules, 20 mg (14-count)
Model:
NDC 70000-0232-1
Recall #: D-0026-2022
Lot Numbers:
BT001594C

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 88809
Status: Resolved
Manufacturer: Dr. Reddy's Laboratories, Inc.
Sold By: Cardinal Health
Manufactured In: United States
Units Affected: 8,976 bottles
Distributed To: Nationwide
Agency Last Updated: October 22, 2021

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.